285 related articles for article (PubMed ID: 7050615)
21. [Current clinical results of antiplatelet medication].
Ordinas A
Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
[No Abstract] [Full Text] [Related]
22. Platelet aggregation and atherosclerosis.
Valladares BK; Lemberg L
Heart Lung; 1986 Mar; 15(2):211-4. PubMed ID: 3633253
[TBL] [Abstract][Full Text] [Related]
23. [Spontaneous thrombocyte aggregation in patients with ischemic cardiopathy. Effect of anti-aggregant treatment on thrombocyte function and other coagulation factors].
Niţă I; Papilian M; Theodorini S; Stroescu V
Med Interne; 1984; 22(2):113-22. PubMed ID: 6740182
[No Abstract] [Full Text] [Related]
24. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
Turpie AG
Prog Clin Biol Res; 1982; 89():31-62. PubMed ID: 7051035
[TBL] [Abstract][Full Text] [Related]
25. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
de Gaetano G; Cerletti C; Bertelè V
Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469
[No Abstract] [Full Text] [Related]
26. [Inhibitors of platelet aggregation in the therapy of arteriosclerosis obliterans].
Zabel Langhennig R
Z Gesamte Inn Med; 1979 May; 34(10):117-20. PubMed ID: 483916
[TBL] [Abstract][Full Text] [Related]
27. [Thrombosis, embolism and aggregation inhibitors in surgery].
Zekert F
Fortschr Med; 1976 Nov; 94(31):1791-8. PubMed ID: 1002084
[TBL] [Abstract][Full Text] [Related]
28. [Anti-aggregation therapy of patients with ischemic heart disease].
Liusov VA; Savenkov MP
Ter Arkh; 1988; 60(8):55-9. PubMed ID: 3227479
[No Abstract] [Full Text] [Related]
29. [Prophylactic value of platelet anti-aggregants in coronary disease].
Verstraete M
Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
[No Abstract] [Full Text] [Related]
30. [Hypercoagulability and cerebral infarction].
Matsuda T
No To Shinkei; 1986 Apr; 38(4):317-27. PubMed ID: 3013261
[No Abstract] [Full Text] [Related]
31. [Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
Ostendorf P
Internist (Berl); 1979 Nov; 20(11):539-46. PubMed ID: 396265
[No Abstract] [Full Text] [Related]
32. Clinical aspects of antiplatelet therapy.
Sherry S
Semin Hematol; 1985 Apr; 22(2):125-34. PubMed ID: 3890191
[No Abstract] [Full Text] [Related]
33. [Critical approach to a therapeutic trial in secondary prevention of cerebral ischemic accidents by antiaggregants].
Guiraud-Chaumeil B
Presse Med; 1983 Dec; 12(48):3045-8. PubMed ID: 6228912
[No Abstract] [Full Text] [Related]
34. [Clinical application and evaluation of anti-platelet agents].
Yasunaga K
Nihon Rinsho; 1978 Dec; 36(12):3884-94. PubMed ID: 372628
[No Abstract] [Full Text] [Related]
35. [Is modern anti-aggregation therapy effective?].
Hladovec J
Cas Lek Cesk; 1984 May; 123(21):630-5. PubMed ID: 6744376
[No Abstract] [Full Text] [Related]
36. Drug trials in prevention of occlusion of aorta--coronary artery vein grafts.
Chesebro JH; Fuster V
J Thorac Cardiovasc Surg; 1982 Jan; 83(1):90-3. PubMed ID: 7033674
[No Abstract] [Full Text] [Related]
37. Are agents affecting platelet functions clinically useful?
Verstraete M
Am J Med; 1976 Dec; 61(6):897-914. PubMed ID: 795299
[TBL] [Abstract][Full Text] [Related]
38. [Aftercare of heart infarct patients to reduce the risk of a subsequent infarction].
Offerhaus L
Ned Tijdschr Geneeskd; 1983 Apr; 127(16):673-9. PubMed ID: 6134240
[No Abstract] [Full Text] [Related]
39. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
Shalaev SV
Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554
[No Abstract] [Full Text] [Related]
40. Aspirin and recurrent myocardial infarction.
Jones RJ
JAMA; 1980 Aug; 244(7):667-8. PubMed ID: 6993715
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
